Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
1-2H3/b12-7-
Chemical Name: (2S)-2-[(2R)-2-[(R)-methoxy[(2S)-1-[(3R
which in May 2013 was approved in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD)
It serves as a useful chemical tool to further validate and develop novel treatments of osteoporosis via promoting bone formation
the cardiac transient outward potassium current
SPR741 TFA Size:Contact [email protected] for quotation 1-2H3/b12-7-SPR741 TFA (NAB741 TFA) is a cationic peptide derived from polymyxin B and is a potentiator molecule. SPR741 TFA increases the permeability of the outer membrane of Gram negative bacteria and is used to treat severe Gram negative bacteria infections. SPR741 TFA inhibits multidrug resistant Gram negative bacteria. The spectrum of activity of the antibiotic can be widened when used in combination with SPR741 TFA. Product information Molecular Weight:
US$ 226.68
US$ 203.15
US$ 203.15
US$ 160.83
US$ 76.52
US$ 203.15